Well-established tumor markers useful in the routine diagnosis of GC patients are carbohydrate antigen 72-4 (CA 72-4), carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9). This evidence concerns the gene CEACAM5 and neoplasm.